Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) has received a consensus rating of “Moderate Buy” from the four analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokers that […]

Related Keywords

, Amneal Pharmaceuticals Company Profile , Neuberger Berman Group , Amneal Pharmaceuticals Stock Performance , Blackrock Inc , Goldman Sachs Group , Millennium Management , Amneal Pharmaceuticals Inc , News Ratings For Amneal Pharmaceuticals Daily , Vanguard Group Inc , Morgan Stanley , Amneal Pharmaceuticals , Get Rating , Marketbeat Ratings , Berman Group , Amneal Pharmaceuticals Daily ,